who took the opportunity to present themselves to the international market was Swedish Iconovo, which develops inhalers with associated pharmaceutical formulations. BioStock was on site in London and had a chat with Iconovo's CEO Orest Lastow about the company's participation in the congress, as well as its business strategy and upcoming restructuring.
Watch the video interview with Orest Lastow from LSX World Congress in London here (English subtitles available):
The content of BioStock's news and analysis is independent, but BioStock's operations are to some extent financed by companies in the industry. This post refers to a company from which BioStock has received funding.
|
Published February 12, 2020
Video interview: Iconovo's CEO presented the company at LSX World Congress
Last week it was time again for the major investor and partnering meeting LSX World Congress in London. The sixth edition of the life science congress offered companies, investors and VC funds two days of exciting company presentations, seminars and meetings. One of the companies